RATIONALE: There are limited therapeutic options for patients with COVID-19-related acute respiratory distress syndrome (ARDS) with inflammation-mediated lung injury. Mesenchymal stromal cells offer promise as immunomodulatory agents. OBJECTIVES: …
STUDY OBJECTIVES: Obstructive sleep apnea (OSA) and other sleep disorders overlap with co-morbidities associated with poor outcomes related to SARS-CoV-2 infection. However, the prevalence of OSA among patients hospitalized for COVID-19 and …